|
(V950) |
RAAS inhibition differentially modulates copeptin levels in hyponatremic and normonatremic patients with reduced ejection fraction |
| |
|
N. Deubner, G. Güder, D. Berliner, S. Brenner, M. Fassnacht, C. W. Hamm, G. Ertl, C. E. Angermann, S. Störk (Bad Nauheim, Würzburg, Hannover) |
|
|
Diskussion |
|
(V951) |
Akute hämodynamische Verbesserung nach Parachute® Device Implantation |
| |
|
T. Schmidt, C. Frerker, T. Thielsen, U. Schäfer (Hamburg) |
|
|
Diskussion |
|
(V952) |
IBP – a new agent for treatment of heart failure |
| |
|
M. Czolbe, M. Mühlfelder, S. Olivares, V. Pekarek, P. Arias-Loza, O. Ritter (Würzburg) |
|
|
Diskussion |
|
(V953) |
AAV9-mediated expression of Cre recombinase enables fast and highly efficient gene knockout in the adult mouse heart |
| |
|
S. Werfel, A. Jungmann, L. H. Lehmann, J. Ksienzyk, R. Bekeredjian, Z. Kaya, B. Leuchs, A. Nordheim, J. Backs, S. Engelhardt, H. A. Katus, O. J. Müller (München, Heidelberg, Tübingen) |
|
|
Diskussion |
|
(V954) |
Metformin Protects Against Cardiac Mitochondrial Dysfunction and Improves Insulin Response in Rats fed High Fat diet |
| |
|
A. Schrepper, M. Schwarzer, T. Doenst (Jena) |
|
|
Diskussion |
|
(V955) |
Review of the safety and electrocardiographic findings with the use of LV Augmentation via permanent alginate hydrogel implants in severe heart failure patients |
| |
|
N. Frey, R. Lee, A. Hinson, K. Matschke, R. Bauernschmitt (Kiel, Dresden, Ulm; San Francisco, Mason, US) |
|
|
Diskussion |